Influenza A virus medicament screening yeast two-hybrid system and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHENZHEN CENT FOR DISEASE CONTROL & PREVENTION
- Publication Date
- 2013-07-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of genetic engineering, in particular to a target-specific influenza A virus drug screening yeast two-hybrid system and its application. Background technique
[0002] Influenza viruses belong to the Orthomyxoviridae family (Orthomyxoviridae), which are negative-strand RNA viruses with envelopes. Members include influenza A, B, and C. Currently, influenza A and B mainly infect humans. The genomes of influenza A and B viruses contain 8 segments, which are single-strand and negative-strand RNAs, encoding at least 10 proteins respectively. Influenza A viruses can be divided into 1-16 HA subtypes and 1-9 NA subtypes according to the different antigenic properties of hemagglutinin (HA) and neuraminidase (NA) on the surface of the virus. Influenza viruses currently causing human infections are mainly H1 (N1), H3 (N2) subtypes and B influenza viruses. Influenza virus RNA-dependent RNA polymerase by PB 1 , PB 2 ,...